Contraline, Inc.
Biotechnology company · Charlottesville, Virginia, United States
Contraline, Inc. is a biotechnology company headquartered in Charlottesville, Virginia, United States. Its earliest recorded incorporation is in 2017. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.4 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $56 million sold in a notice filed in 2026.
Contraline at a glance
What does Contraline do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $1.4 million in total (2024 to 2025). NIH funding came from the National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $55.8 million sold (2026).
Frequently asked questions about Contraline
Where is Contraline headquartered?
Contraline, Inc. is headquartered in Charlottesville, Virginia, United States.
What does Contraline do?
Contraline, Inc. is a biotechnology company.
When was Contraline founded?
The earliest incorporation on record for Contraline, Inc. is in 2017, according to public company registers.
Similar companies
- Hemoshear Therapeutics, Inc.Charlottesville, Virginia, United States
- Barron Associates, Inc.Charlottesville, Virginia, United States
- SoundPipeCharlottesville, Virginia, United States
- Atelerix Life Sciences Inc.Charlottesville, Virginia, United States
- Gene Solutions LLCCharlottesville, Virginia, United States
- Zielbio, Inc.Charlottesville, Virginia, United States
- Cavion, Inc.Charlottesville, Virginia, United States
- Luna Labs USA LLCCharlottesville, Virginia, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences